the results of a pilot study on the use of oral medroxyprogesterone acetate ( provera-upjohn ) at high dose in a series of 50 consecutive women with advanced breast ( 30 cases ) and endometrial carcinoma ( 20 cases ) are reported .
C0065864
medroxyprogesterone acetate
C0699702
provera